Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

719 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
FET-PET for malignant glioma treatment planning.
Niyazi M, Geisler J, Siefert A, Schwarz SB, Ganswindt U, Garny S, Schnell O, Suchorska B, Kreth FW, Tonn JC, Bartenstein P, la Fougère C, Belka C. Niyazi M, et al. Among authors: bartenstein p. Radiother Oncol. 2011 Apr;99(1):44-8. doi: 10.1016/j.radonc.2011.03.001. Epub 2011 Mar 30. Radiother Oncol. 2011. PMID: 21458093
Molecular imaging of gliomas with PET: opportunities and limitations.
la Fougère C, Suchorska B, Bartenstein P, Kreth FW, Tonn JC. la Fougère C, et al. Among authors: bartenstein p. Neuro Oncol. 2011 Aug;13(8):806-19. doi: 10.1093/neuonc/nor054. Epub 2011 Jul 13. Neuro Oncol. 2011. PMID: 21757446 Free PMC article. Review.
MRI-suspected low-grade glioma: is there a need to perform dynamic FET PET?
Jansen NL, Graute V, Armbruster L, Suchorska B, Lutz J, Eigenbrod S, Cumming P, Bartenstein P, Tonn JC, Kreth FW, la Fougère C. Jansen NL, et al. Among authors: bartenstein p. Eur J Nucl Med Mol Imaging. 2012 Jun;39(6):1021-9. doi: 10.1007/s00259-012-2109-9. Epub 2012 Apr 11. Eur J Nucl Med Mol Imaging. 2012. PMID: 22491781
FET-PET assessed recurrence pattern after radio-chemotherapy in newly diagnosed patients with glioblastoma is influenced by MGMT methylation status.
Niyazi M, Schnell O, Suchorska B, Schwarz SB, Ganswindt U, Geisler J, Bartenstein P, Kreth FW, Tonn JC, Eigenbrod S, Belka C, la Fougère C. Niyazi M, et al. Among authors: bartenstein p. Radiother Oncol. 2012 Jul;104(1):78-82. doi: 10.1016/j.radonc.2012.04.022. Epub 2012 Jun 5. Radiother Oncol. 2012. PMID: 22673727
Prediction of oligodendroglial histology and LOH 1p/19q using dynamic [(18)F]FET-PET imaging in intracranial WHO grade II and III gliomas.
Jansen NL, Schwartz C, Graute V, Eigenbrod S, Lutz J, Egensperger R, Pöpperl G, Kretzschmar HA, Cumming P, Bartenstein P, Tonn JC, Kreth FW, la Fougère C, Thon N. Jansen NL, et al. Among authors: bartenstein p. Neuro Oncol. 2012 Dec;14(12):1473-80. doi: 10.1093/neuonc/nos259. Epub 2012 Oct 22. Neuro Oncol. 2012. PMID: 23090986 Free PMC article.
Extrastriatal binding of [¹²³I]FP-CIT in the thalamus and pons: gender and age dependencies assessed in a European multicentre database of healthy controls.
Koch W, Unterrainer M, Xiong G, Bartenstein P, Diemling M, Varrone A, Dickson JC, Tossici-Bolt L, Sera T, Asenbaum S, Booij J, Kapucu OL, Kluge A, Ziebell M, Darcourt J, Nobili F, Pagani M, Hesse S, Vander Borght T, Van Laere K, Tatsch K, la Fougère C. Koch W, et al. Among authors: bartenstein p. Eur J Nucl Med Mol Imaging. 2014 Oct;41(10):1938-46. doi: 10.1007/s00259-014-2785-8. Epub 2014 May 8. Eur J Nucl Med Mol Imaging. 2014. PMID: 24806112
719 results